Ownership history in XTX Topco Ltd · 12 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ALLOGENE THERAPEUTICS INC (ALLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 476,307 | -297,896 | -38.5% | 0.02% | $653K | $1.37 |
| 2025 Q3 | ADDED | 774,203 | +746,431 | +2687.7% | 0.05% | $960K | $1.24 |
| 2025 Q2 | ADDED | 27,772 | +7,026 | +33.9% | 0.00% | $31K | $1.13 |
| 2025 Q1 | REDUCED | 20,746 | -137,791 | -86.9% | 0.00% | $30K | $1.46 |
| 2024 Q4 | ADDED | 158,537 | +122,772 | +343.3% | 0.03% | $338K | $2.13 |
| 2024 Q1 | ADDED | 35,765 | +379 | +1.1% | 0.02% | $160K | $4.47 |
| 2023 Q4 | REDUCED | 35,386 | -38,604 | -52.2% | 0.02% | $114K | $3.21 |
| 2023 Q3 | ADDED | 73,990 | +28,159 | +61.4% | 0.04% | $235K | $3.17 |
| 2023 Q2 | ADDED | 45,831 | +259 | +0.6% | 0.04% | $228K | $4.97 |
| 2023 Q1 | REDUCED | 45,572 | -71,264 | -61.0% | 0.05% | $225K | $4.94 |
As of 2025 Q4 — sorted by position size